The Worsening Renal Perfusion Index Predicts the Prognoses of Heart Failure Patients Treated with Sacubitril/Valsartan

INTRODUCTION: Sacubitril/valsartan (S/V) reduces all-cause mortality in patients with heart failure with reduced ejection fraction (HFrEF), but it may decline their estimated glomerular filtration rates (eGFR). In addition to eGFR, this clinical study aimed to develop a blood urea nitrogen (BUN)-bas...

Descripción completa

Detalles Bibliográficos
Autores principales: Hsu, Wan-Tseng, Cheng, Yu-Yang, Yang, Tsun-Yu, Chang, Chao-Kai, Lin, Yi-Hsuan, Lee, Chii-Ming, Huang, Tao-Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664343/
https://www.ncbi.nlm.nih.gov/pubmed/37708880
http://dx.doi.org/10.1159/000534095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664343/
https://www.ncbi.nlm.nih.gov/pubmed/37708880
http://dx.doi.org/10.1159/000534095

Ejemplares similares